Advansix, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US00773T1016
USD
15.73
-0.13 (-0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Advansix, Inc. stock-summary
stock-summary
Advansix, Inc.
Specialty Chemicals
AdvanSix Inc. is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia. The Company offers ammonium sulfate, which is used by customers as a nitrogen-based fertilizer. It produces ammonium sulfate fertilizer as part of its manufacturing process. The Company manufactures ammonium sulfate fertilizers including Sulf-N and Sulf-N 26. The Company provides AdvanSix Aegis nylon resins and Aegis barrier nylon resins. Its nylon resins are a preferred choice in food, liquid, and consumer packaging along with mono/multifilament products, carpet fibers, automotive compounding and more. It offers Capran biaxially oriented nylon films.
Company Coordinates stock-summary
Company Details
300 Kimball Dr Ste 101 , PARSIPPANY NJ : 07054-2181
stock-summary
Tel: 1 973 5261800
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 65 Schemes (54.55%)

Foreign Institutions

Held by 94 Foreign Institutions (5.56%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Marberry
Independent Chairman of the Board
Ms. Erin Kane
Chief Executive Officer, Director
Mr. Paul Huck
Independent Director
Mr. Darrell Hughes
Independent Director
Mr. Todd Karran
Independent Director
Mr. Daniel Sansone
Independent Director
Ms. Sharon Spurlin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
410 Million
(Quarterly Results - Jun 2025)
Net Profit:
31 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 647 Million (Micro Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

269.34%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

9.39%

stock-summary
Price to Book

0.79